Growing Cancer Prevalence Is Anticipated To Fuel The Flow Cytometry In The Oncology And Immunology Market Growth: Strengthening the Growth Trajectory of the Flow Cytometry In Oncology And Immunology Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Flow Cytometry In Oncology And Immunology Market Through 2025?
The oncology and immunology market for flow cytometry has seen quick expansion in the past few years. It is projected to escalate from a value of $2.11 billion in 2024 to reach $2.33 billion by 2025, maintaining a compound annual growth rate (CAGR) of 10.4%. Factors contributing to the growth during the historical timeframe include progress in cancer and immunology studies, an increase in diagnostic applications, a growing number of autoimmune diseases, drug development, and ongoing clinical trials.

What's the Projected Size of the Global Flow Cytometry In Oncology And Immunology Market by 2029?
An explosive increment is anticipated in the market size of flow cytometry in oncology and immunology in the impending years. A growth of up to $3.46 billion is projected by 2029 with a compound annual growth rate (CAGR) of 10.4%. The upcoming period's expansion can be correlated with integrations into genomics and proteomics, the uptake of single-cell analysis, ballooning applications in the field of infectious diseases, an escalating count of cancer cases, and point-of-care flow cytometry. The key trends identified for the forecast duration encompass immunophenotyping in the realm of immunotherapy, downscaling of flow cytometry systems, multiparametric analysis, a pivot towards spectral flow cytometry along with cooperative research schemes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Top Growth Drivers in the Flow Cytometry In Oncology And Immunology Industry: What's Accelerating the Market?
The escalating incidences of cancer are anticipated to fuel the expansion of flow cytometry in the field of oncology and immunology. Cancer is an umbrella term for a collection of illnesses marked by the unregulated multiplication and dissemination of abnormal cells within the body. Flow cytometry is a prevalent methodology employed in oncology and immunology for the examination of cancer and immune cells. For instance, information from the Macmillan Cancer Support, a healthcare charity based in the UK, revealed that 3 million individuals were diagnosed with cancer in 2020. The forecast highlights an estimated growth that could affect 3.5 million people by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the rising frequency of cancer is bolstering the expansion of flow cytometry in the oncology and immunology market sectors.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

What Trends Will Shape the Flow Cytometry In Oncology And Immunology Market Through 2029 and Beyond?
In the oncology and immunology markets, a prominent trend is the adoption of technological innovations in the field of flow cytometry. To maintain a competitive edge, major firms in this sector are embracing new technologies. For instance, in September 2022, Becton Dickinson, a US-based provider of medical technology, introduced the BD Research Cloud for flow cytometry in the areas of oncology and immunology. This cloud-based software system simplifies the flow cytometry process for researchers working in diverse areas, such as immunology, virology, infectious disease, and cancer monitoring, thus expediting higher-quality studies with faster insights. Innovative technologies like BD Horizon RealYellow and RealBlue Reagents, as well as the newly launched BD FACSDiscover S8 Cell Sorter equipped with BD CellView Image Technology, are being harnessed by BD. These advancements enhance flow cytometry capabilities, empowering researchers to facilitate and push the boundaries of their pioneering studies. Tailored specifically for BD equipment and reagents, the BD Research Cloud operates on an industry-standard cloud infrastructure.

What Are the Main Segments in the Flow Cytometry In Oncology And Immunology Market?
The flow cytometry in oncology and immunology market covered in this report is segmented -

1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12469&type=smp

Which Top Companies are Driving Growth in the Flow Cytometry In Oncology And Immunology Market?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason

Which Regions Will Dominate the Flow Cytometry In Oncology And Immunology Market Through 2029?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.